Pharmacokinetic analysis revealed it to be orally active with significantly increased metabolic stability, exhibiting a plasma half-life of 335.5 minutes, allowing for prolonged systemic availability [2]
One of the most interesting developments I continue to observe is the growing attention toward copper peptides, particularly GHK-Cu
Active glutathione (also known as reduced glutathione) can be administered intravenously (IV), in a nebulizer and orally in liposomal delivery systems
Individuals with Wilson's disease or copper metabolism disorders should avoid GHK-CU entirely
While this mechanism prevents premature cell death, it simultaneously promotes the accumulation of damaged and dysfunctional cells, which disrupt tissue homeostasis and contribute to the progression of age-related diseases
Loren Pickart in 1973 from human plasma albumin, this compound sparked over four decades of research into its remarkable regenerative properties